Company intelligence / Profile preview
Stemmatters
Guimarães, Portugalstemmatters.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
Stemmatters operates as a hybrid CDMO and biotech innovator specializing in cell/tissue products and advanced therapy medicinal products, particularly for regenerative medicine. It focuses on process development, GMP manufacturing, and biomaterial-enabled combination therapeutics for clients and partners, alongside developing its internal preclinical pipeline.
- Therapeutic areas
- Other
- Modalities
- Cell therapyBiologicBlood-derived biologicalsExosome-based therapyMedical deviceCombination productBiomaterialAdvanced therapy medicinal product
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
PluristyxMicrofluidXCAR T-REX International ConsortiumPAT4CGT International Consortium
Beyond the preview
Go deeper on Stemmatters.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stemmatters.